About HATIP

A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.

Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.

Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.

latest aidsmap news

• Large HIV vaccine study will not go ahead
• Swiss court rules all people with HIV can be criminally liable for transmission, even if untested
• Genital shedding of HIV in women with undetectable viral load: less of it, but still happening
• Microbicides could prevent more infections in men than in women
• Knowledge of STIs poor in rural Tanzania - associated with risky sex and infection with HIV
• HIV treatment effective for infants in resource-limited settings
• Need for vigilance: two cases of abacavir allergy despite pre-treatment screening all-clear
• One third of people with HIV have experienced sexual difficulties in the past month
• Differing causes of lung infections in HIV-positive patients: implications for diagnosis and treatment
• Roche to halt HIV drug research